Free tool
FAERS Monitor: Depakote
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019680 or its brand name (Depakote, Divalproex Sodium). Reports on generic versions are filed under their own applications.
Reports
42,540
Serious
29,035
68% of reports
Hospitalization
14,288
Death reported
2,388
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective2,910
- seizure2,465
- weight increased1,996
- off label use1,989
- nausea1,960
- fatigue1,819
- pain1,809
- somnolence1,753
- tremor1,643
- fall1,640
- anxiety1,604
- vomiting1,537
- headache1,474
- insomnia1,435
- depression1,433
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,146 |
| 2005 | 1,255 |
| 2006 | 1,190 |
| 2007 | 1,179 |
| 2008 | 1,195 |
| 2009 | 2,479 |
| 2010 | 2,155 |
| 2011 | 2,052 |
| 2012 | 2,043 |
| 2013 | 1,760 |
| 2014 | 1,854 |
| 2015 | 2,475 |
| 2016 | 2,644 |
| 2017 | 2,205 |
| 2018 | 2,092 |
| 2019 | 2,129 |
| 2020 | 1,907 |
| 2021 | 1,991 |
| 2022 | 2,047 |
| 2023 | 1,770 |
| 2024 | 1,783 |
| 2025 | 1,875 |
| 2026 | 1,309 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,011,619 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| seizureSignal | 2,465 | 10.8 | 10.4 | 21,464 |
| tremorSignal | 1,643 | 4.9 | 4.7 | 5,138 |
| weight increasedSignal | 1,996 | 4.4 | 4.3 | 5,321 |
| somnolenceSignal | 1,753 | 4.3 | 4.1 | 4,496 |
| depressionSignal | 1,433 | 3.1 | 3.0 | 2,081 |
| anxietySignal | 1,604 | 2.8 | 2.7 | 1,865 |
| insomniaSignal | 1,435 | 2.7 | 2.5 | 1,512 |
| fallSignal | 1,640 | 2.4 | 2.3 | 1,412 |
| vomiting | 1,537 | 1.6 | 1.5 | 370 |
| pain | 1,809 | 1.5 | 1.4 | 266 |
| nausea | 1,960 | 1.2 | 1.2 | 84 |
| headache | 1,474 | 1.2 | 1.1 | 34 |
| fatigue | 1,819 | 1.2 | 1.1 | 39 |
| off label use | 1,989 | 1.1 | 1.1 | 28 |
| drug ineffective | 2,910 | 1.1 | 1.1 | 24 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.